Phase 3b/4 Safety Trial of Nivolumab Combined with Ipilmumab in Subjects with Previously Untreated, Advanced or Metastatic RCC
Clinical Trial Grant
Awarded By
Merck Sharp & Dohme
Start Date
January 25, 2018
End Date
July 15, 2021
Awarded By
Merck Sharp & Dohme
Start Date
January 25, 2018
End Date
July 15, 2021